PA News | PD Community News

Here you may read about other Parkinson's disease related news.

PA News

A New Drug XPro1595 May Slow Progression of Parkinsonís Disease

Study of First Parkinson's Disease Vaccine Shows Encouraging Results

NeuroDerm Announces Eligibility for European Union Centralized Procedure for ND0612H

"How to Live Well with Parkinson's Disease" Seminar

The Michael J. Fox Foundation for Parkinsonís Research Awards $2M Grant to Biotie for Parkinson's Dementia Clinical Study

A New Study Reveals Why Coffee Protects Some Against Developing Parkinson's Disease

Mitochondria-Targeted Therapeutic Discovery Research Project Underway

MRI Brain Scans Detect People with Early Parkinson's Disease

The Michael J. Fox Foundation for Parkinson

Speech Treatment for Parkinson Disease: The Science and Practice of LSVT LOUDô

First Ever World Parkinson Coalition Scientific Update

Medicare & Parkinsonís Disease: Therapy Caps and the Exceptions Process

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson`s Disease and Movement Disorders

Largest Ever Trial in Parkinson`s Disease Shows That For Long Term Treatment Levodopa is Better Than Newer Drugs

Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Verciseô DBS System For Patients With Parkinson`s Disease

University of Alabama Study Finds LRRK2 May Be Key to Combating Parkinson`s Disease

National Parkinson Foundation Study Finds U.S. Neurologist Care Saves 4,600 Lives of People with Parkinson`s Disease Each Year

FDA Approves Expanded Label for AZILECTģ for Treatment Across All Stages of Parkinsonís Disease

UCLA Researchers Identify New Gene Involved in Parkinson's Disease

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA)

Teva`s Parkinson Drug Now Marketed in Japan

Rice University Researcher Rebooting Deep Brain Stimulation

Achieve Daily Victories Free Seminar Focusing on a Treatment for Parkinson`s Disease and Essential Tremor

Specialized Care Urged for Treating Parkinson`s Disease

Exenatide Has Potential as a Disease Modifying Agent in Parkinson`s Disease

Adamas Pharmaceuticals Provides Data Update On ADS-5102 At The American Academy Of Neurology Annual Meeting

Civitas Announces Positive Results from Phase II Inhaled Levodopa Trial

Parkinson`s Support Group at Capital Health Medical Center

AbbVie Announces Availability of New Advanced Parkinson`s Treatment in Canada

Impax Pharmaceuticals Resubmits New Drug Application for RYTARYô (Carbidopa and Levodopa) Extended-Release Capsules (IPX066)

Boston Scientific Corporation Enrolls the First Patient in a New Registry to Evaluate the Value of the Verciseô Deep Brain Stimulation (DBS) System

Brain Imaging Tracer for Parkinson`s Disease

Parkinson`s Disease and Pesticides: What's the Connection?

Google Glasses Could Help Parkinsonís Sufferers

FDA Approves Vanderbilt Trial for Parkinsonís Treatment

Completion of a Study on Retinal Pathology in an Animal Model of Parkinson`s Disease

JFK Neuroscience Institute presents Fling into Spring

Parkinson's Disease Forum for Patients and Caregivers


MRI Interventions' Clearpoint System Now Utilized at Emory University in Atlanta

Potential Parkinson's Therapy Secures $23 Million for Testing from NIH after Foundation Funding

"Electronic Skin": New Hope for Parkinsonís Patients

Parkinson`s Organizations Applaud Efforts to Bring More Drugs to Market

Advances in Treating Parkinsonís, Essential Tremor, Dystonia, Touretteís, and Obsessive-Compulsive Disorder

The Communication Connection: The Art & Science of Staying in Touch while Living Well with Parkinsonís

NeuroDerm Announces Enrollment in a Second Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinson's Disease

UCLA Researchers Link Common Pesticides to Parkinsonís Disease

New Research Offers Explanation About Why Deep Brain Stimulation Works

Study Evaluating Additional Indications for Tevaís Azilect

FDA Approves Chelsea Therapeuticsí Northera for Treatment of Neurogenic Orthostatic Hypotension

Berg And The Parkinson's Institute And Clinical Center Announce Key Clinical Study Focused On Game-changing Innovations In Parkinson's Disease Biomarker Discovery

National Parkinson Foundation Partners with SBR Health Provide Increased Access to Expert Parkinson's Disease Care

For Workers with Parkinson's, It's a Tough Job

PatientsLikeMe and Sage Bionetworks Launch Open Science Study for People with Parkinson's Disease

New Potential Cell Therapy for Parkinsonís

Crossing the Lines Between Parkinson

Researchers ID More Pesticides Linked to Parkinson's, Gene that Increases Risk

Ruby Foundation to Merge with Davis Phinney Foundation

Device to Help Prevent Falls Invented in Australia

Research Identifies Enzyme that Blocks Paths to Parkinson's Disease

Amarantus In-licenses Levadopa-induced Dyskinesia Phase 2b-ready Eltoprazine from PGI Drug Discovery

Gene Found That Protects Against Neurodegenerative Diseases

Novel Gene Therapy for Parkinsonís Disease Clears Hurdle

Asleep During Brain Surgery: A Comfortable Alternative for Patients with Parkinson's Disease

Disparities Among Which Parkinsonís Patients Receive Deep Brain Stimulation

Parkinson's Research Study Shows Inosine Compound Raises Urate Levels

Stanford Researchers Record Data from Brain of Ambulatory Parkinson's Patient

Ohio State Study Shows Exercise Improves Depression in Parkinson's Patients

Medtronic Recently Received FDA Approval of Updated Labeling for DBS for Parkinsonís Disease

Neurologist at Emory Awarded $3 Million Life Sciences Breakthrough Award

ďSmart glassesĒ to Improve Gait of Parkinson

Researchers Discover That an Important Clue to Diagnosing Parkinsonís Disease May Lie Just Beneath the Skin

NINDS Sponsors Parkinsonís Meeting to Identify Challenges and Define Research Priorities

Gene-Silencing Study Finds New Targets for Parkinson's Disease

Genetic Mutation Increases Risk of Parkinson's Disease from Pesticides

UCLA and Emory Researchers Find a Chemical Signature for 'Fast' Form of Parkinsonís

US WorldMeds Launches Final Phase III Trial to Study Myobloc Injections to Treat Drooling

New Parkinson's Disease Genes Discovered by the Parkinson's Institute and Clinical Center and Population Diagnostics, Inc.

MRI Interventions' ClearPoint System Facilitates Asleep DBS Surgery at San Francisco VA Medical Center for Veterans with Parkinson's Disease

The Michael J. Fox Foundation Expands Fox Trial Finder To Help Accelerate Parkinson's Trials Worldwide

PD Community News


Warning: mysql_fetch_assoc(): supplied argument is not a valid MySQL result resource in /home/parky/domains/parkinsonalliance.org/public_html/news.php on line 167

Back to top